Kraig Biocraft laboratories names first new member of expanded Board of Directors

September 18, 2019 Off By BusinessWire

ANN ARBOR, Mich.–(BUSINESS WIRE)–$KBLB #KBLB–Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that it has selected Mr. Anurag Gupta for its expanded Board of Directors. Among the many significant accomplishments during his career, Mr. Gupta has served as: the CEO of Global Data Services for TBG, the President for Europe, Middle East, and Africa region for BrightPoint, Inc, and the Executive Vice President of the CMS Division at IHS Markit. Mr. Gupta currently serves as an Independent Director on the boards of Roseburg Forest Products Co. and Drive My Way, Inc.

“We are pleased to welcome Anurag as the first, of several, new independent directors to be joining Kraig Lab’s board,” said chairman and CEO, Kim Thompson. “Anurag’s background and experience in corporate management, technology development, international operations, and investor relations will be an asset to the Company as we continue to grow.”

The addition of Mr. Gupta to the board will expand the overall skillset, perspective and experience necessary to support and drive growth for all of the Company’s stakeholders.

Mr Gupta’s term will begin during the fourth quarter and he will serve on the audit committee and compensation committees for the duration of his time as a director.

“I am excited about joining the Board of Kraig Labs and look forward to working alongside our Founder and CEO, Kim Thompson and my fellow Board members,” said Mr. Gupta. “It is exciting to be a part of an innovative biotechnology company that is doing amazing work towards the development and commercialization of Spider Silk technology.”

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company, is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Contacts

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

[email protected]